Invitrogen Corporation Announces Second Quarter 2007 Results; $500 Million Share Repurchase Authorization

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its second quarter ended June 30, 2007. Revenues for the second quarter were $322 million, an increase of 13 percent over the $285 million for 2006, excluding the impact of discontinued operations.